Navigation Links
Scientists May Isolate Stem Cells From Rats, Other Mammals
Date:12/25/2008

Achievement would be a real advance since these cells more closely mimic those of humans

WEDNESDAY, Dec. 24 (HealthDay News) -- Researchers say they've found a formula to capture indefinitely the basic embryonic stem cells of a mammal, including long-sought rat stem cells.

If the findings hold up, scientists will then be able to mimic human disease in readily produced, genetically altered strains of rats. As humans and rats are physiologically very similar, medical study of rats is more directly applicable to people than mice. For example, people and rats tend to respond to drugs in a similar manner, while the rodents' larger size also makes them easier to work than, say, mice.

The new studies, conducted by teams at the University of Edinburgh in England and the University of Southern California (USC), Los Angeles, were published in the Dec. 26 issue of Cell.

Since 1981, researchers have been able to genetically alter mice embryonic stem cells to create and study disease models. They have been unable to capture and isolate the cells from rats or other animals.

Earlier in 2008, the simple two- to three-ingredient formula was shown to keep mice embryonic cells in their undifferentiated or "pluripotent" state, retaining their ability to later differentiate into any cell or tissue type. This allows them to multiply into generic stem cells.

Human embryonic stem cell lines do exist, but ethical concerns and other issues do not always make them the best or easiest cells to work with, study author Qi-Long Ying of USC, who worked on both studies, said in a news release issued by the journal's publisher.

"In the past two decades, embryonic stem cells have been routinely used to create loss of function (knockout) or gene replacement (knock-in) mutations by homologous recombination in the mouse, providing an invaluable tool for the functional characterization of genes," Ying's g
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Scientists Create New Means to Study Disease Origins
2. Scientists reveal structure of new botulism nerve toxin subtype
3. Scientists Discover Trigger for Autoimmune Diseases
4. Scientists Spot Key to Cystic Fibrosis Infections
5. Scientists, Physicians, Health, and Environmental Justice Advocates to New Obama EPA Director: We Look Forward to Toxic Chemical Regulatory Reform
6. Seven life scientists get research boost to set up in Europe
7. UC San Diego scientists developing brain imaging methods for studying natural human behavior
8. Scientists ID Enzyme Causing Brain Cell Death
9. NASA scientists provide update on existing remote sensing technology programs and new projects
10. Scientists ID Protein Aiding Breast Cancer Spread
11. UCLA scientists prove endothelial cells give rise to blood stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists May Isolate Stem Cells From Rats, Other Mammals
Scientists May Isolate Stem Cells From Rats, Other Mammals
Other Medicine News:Health News:Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Children's Health Care? 2Health News:Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Children's Health Care? 3Health News:Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Children's Health Care? 4Health News:Fecal Blood Tests Effective at Spotting Colon Cancer 2Health News:Saint Vincent Health System of Erie, Pennsylvania Named One of AARP 2007 Best Employers for Workers Over 50 2Health News:Saint Vincent Health System of Erie, Pennsylvania Named One of AARP 2007 Best Employers for Workers Over 50 3Health News:Saint Vincent Health System of Erie, Pennsylvania Named One of AARP 2007 Best Employers for Workers Over 50 4Health News:Saint Vincent Health System of Erie, Pennsylvania Named One of AARP 2007 Best Employers for Workers Over 50 5Health News:Experts Agree. Ohio's Technology Investment Future Looks Bright 2Health News:Experts Agree. Ohio's Technology Investment Future Looks Bright 3Health News:PNY Technologies and Susan G. Komen for the Cure Partner to Raise Awareness of Breast Cancer 2Health News: Nosespray vaccine using aloe vera has exciting potential, researcher says 2
Breaking Medicine Technology:Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6L A Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 6309 1L A Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 6309 2L A Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 6309 3Par Pharmaceutical to Host Analyst Day on December 3rd 6307 1NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 1NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 2NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 3NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 4NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 5